Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vir Biotechnology, Inc.

5.45
+0.30005.83%
Post-market: 5.450.00000.00%19:58 EDT
Volume:1.34M
Turnover:7.20M
Market Cap:753.40M
PE:-1.29
High:5.48
Open:5.25
Low:5.18
Close:5.15
Loading ...
Apr 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 26, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 26, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 20, 2024

Major Issues Report

Form 8-K - Current report
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 14, 2023

Major Issues Report

Form 8-K - Current report
Nov 04, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2023

Major Issues Report

Form 8-K - Current report
Oct 03, 2023

Major Issues Report

Form 8-K - Current report
Sep 20, 2023

Major Issues Report

Form 8-K - Current report
Aug 04, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2023

Major Issues Report

Form 8-K - Current report
Jul 20, 2023

Major Issues Report

Form 8-K - Current report
Jun 30, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities